Joshua Aiello - 12 Feb 2026 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role: Principal Accounting Officer
Signature: /s/ Andrew Taylor, Attorney-in-Fact
Issuer symbol: OBIO
Transactions as of: 12 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 13 Feb 2026, 17:02:11 UTC
Previous filing: 02 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Aiello Joshua	Principal Accounting Officer	C/O ORCHESTRA BIOMED HOLDINGS, INC., 150 UNION SQUARE DRIVE, NEW HOPE	/s/ Andrew Taylor, Attorney-in-Fact	13 Feb 2026	0001960418

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OBIO	Stock Option (Right to Buy)	Award	$0	+70,000		$0.000000	70,000	12 Feb 2026	Common Stock	70,000	$3.82	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock options will vest as follows: (i) 25% of the stock options will vest on February 12, 2027 (the "Vesting Commencement Date") and (ii) the remaining 75% stock options will vest in equal installments every three months on the same day of the month as the Vesting Commencement Date, starting on May 12, 2027, subject to the Reporting Person's continuous service through such dates.